Zhang Chen, Liu Yang-Wenyi, Chi Zhangcai, Chen Bing
ENT Institute and Department of Otolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.
NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai 200031, China.
PPAR Res. 2020 Dec 22;2020:8864813. doi: 10.1155/2020/8864813. eCollection 2020.
Cholesteatoma is characterized by both the overgrowth of hyperkeratinized squamous epithelium and bone erosion. However, the exact mechanism underlying the hyperproliferative ability of cholesteatoma remains unknown. In this study, we investigated PPAR / expression in human surgical specimens of cholesteatoma and analyzed its functional role as a regulator of epithelial keratinocyte hyperproliferation. We found that the expression of PPAR / was significantly upregulated in cholesteatoma and ligand-activated PPAR / markedly promoted the proliferation of cholesteatoma keratinocytes. Furthermore, we showed that PPAR / activation increased PDK1 expression and decreased PTEN generation, which led to increased phosphorylation of AKT and GSK3 and increased the expression level of Cyclin D1. Overall, our data suggested that the proliferating effect of PPAR / on the cholesteatoma keratinocytes was mediated by the positive regulation of the PDK1/PTEN/AKT/GSK3/Cyclin D1 pathway. These findings warranted further investigation of PPAR / as a therapeutic target for recurrent or residual cholesteatoma.
胆脂瘤的特征是角化过度的鳞状上皮过度生长和骨质侵蚀。然而,胆脂瘤过度增殖能力的确切机制仍不清楚。在本研究中,我们调查了PPAR /在人类胆脂瘤手术标本中的表达,并分析了其作为上皮角质形成细胞过度增殖调节因子的功能作用。我们发现PPAR /在胆脂瘤中的表达显著上调,配体激活的PPAR /明显促进胆脂瘤角质形成细胞的增殖。此外,我们表明PPAR /激活增加了PDK1的表达并减少了PTEN的产生,这导致AKT和GSK3的磷酸化增加以及细胞周期蛋白D1的表达水平增加。总体而言,我们的数据表明PPAR /对胆脂瘤角质形成细胞的增殖作用是由PDK1/PTEN/AKT/GSK3/细胞周期蛋白D1途径的正向调节介导的。这些发现值得进一步研究将PPAR /作为复发性或残留性胆脂瘤的治疗靶点。